Azenta Life Sciences
A Scientist III at Azenta leads the R&D of next-generation gene synthesis technologies, focusing on high-throughput, low-cost, and high-fidelity pathways. The role involves tackling technical challenges with difficult sequences, optimizing existing workflows, and solving complex issues in gene cloning and assembly. Candidates must possess deep expertise in molecular biology techniques and genome editing to drive innovation in the field.
Headquarters
Burlington, Massachusetts, United States
Company Size
1001-5000 employees
Azenta Life Sciences enterprise-wide sample exploration and management solutions accelerate discovery, development and delivery, with speed and precision.
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
1 week ago
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
Nov 13, 2025
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Azenta Life Sciences.
Azenta Life Sciences didn’t post a salary, so this is our estimate from similar listings.
21% below the average for this role
Azenta Life Sciences Launches New Cap Carrier Formats to Expand Sample Management Options
Oct 28, 2025